annual cash & cash equivalents:
$525.54M-$608.00M(-53.64%)Summary
- As of today (September 14, 2025), GH annual cash & cash equivalents is $525.54 million, with the most recent change of -$608.00 million (-53.64%) on December 31, 2024.
- During the last 3 years, GH annual cash & cash equivalents has risen by +$33.34 million (+6.77%).
- GH annual cash & cash equivalents is now -53.64% below its all-time high of $1.13 billion, reached on December 31, 2023.
Performance
GH Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$629.14M-$69.43M(-9.94%)Summary
- As of today (September 14, 2025), GH quarterly cash & cash equivalents is $629.14 million, with the most recent change of -$69.43 million (-9.94%) on June 30, 2025.
- Over the past year, GH quarterly cash & cash equivalents has dropped by -$406.10 million (-39.23%).
- GH quarterly cash & cash equivalents is now -67.58% below its all-time high of $1.94 billion, reached on March 31, 2021.
Performance
GH quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
GH Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -53.6% | -39.2% |
| 3 y3 years | +6.8% | -26.3% |
| 5 y5 years | +266.9% | -32.9% |
GH Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -53.6% | +271.0% | -48.6% | at low |
| 5 y | 5-year | -53.6% | +271.0% | -67.6% | at low |
| alltime | all time | -53.6% | +1464.5% | -67.6% | +184.3% |
GH Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $629.14M(-9.9%) |
| Mar 2025 | - | $698.57M(-16.8%) |
| Dec 2024 | $525.54M(-53.6%) | $839.98M(-15.9%) |
| Sep 2024 | - | $999.07M(-3.5%) |
| Jun 2024 | - | $1.04B(-8.3%) |
| Mar 2024 | - | $1.13B(-3.4%) |
| Dec 2023 | $1.13B(+700.3%) | $1.17B(+1.2%) |
| Sep 2023 | - | $1.15B(-5.7%) |
| Jun 2023 | - | $1.22B(+30.7%) |
| Mar 2023 | - | $937.02M(-7.3%) |
| Dec 2022 | $141.65M(-71.2%) | $1.01B(+5.6%) |
| Sep 2022 | - | $958.04M(+12.2%) |
| Jun 2022 | - | $853.69M(-11.3%) |
| Mar 2022 | - | $962.27M(+3.2%) |
| Dec 2021 | $492.20M | $932.75M(-37.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $1.49B(-17.1%) |
| Jun 2021 | - | $1.79B(-7.7%) |
| Mar 2021 | - | $1.94B(+8.1%) |
| Dec 2020 | $832.98M(+481.6%) | $1.79B(+77.1%) |
| Sep 2020 | - | $1.01B(+8.1%) |
| Jun 2020 | - | $937.83M(+80.3%) |
| Mar 2020 | - | $520.09M(-0.5%) |
| Dec 2019 | $143.23M(+1.9%) | $522.80M(-0.0%) |
| Sep 2019 | - | $522.96M(-4.2%) |
| Jun 2019 | - | $545.63M(+16.9%) |
| Mar 2019 | - | $466.86M(+11.4%) |
| Dec 2018 | $140.54M(+94.4%) | $418.96M(+54.4%) |
| Sep 2018 | - | $271.34M(+3.0%) |
| Jun 2018 | - | $263.43M(+19.0%) |
| Dec 2017 | $72.28M(+115.2%) | $221.32M |
| Dec 2016 | $33.59M | - |
FAQ
- What is Guardant Health, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Guardant Health, Inc.?
- What is Guardant Health, Inc. annual cash & cash equivalents year-on-year change?
- What is Guardant Health, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Guardant Health, Inc.?
- What is Guardant Health, Inc. quarterly cash & cash equivalents year-on-year change?
What is Guardant Health, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of GH is $525.54M
What is the all time high annual cash & cash equivalents for Guardant Health, Inc.?
Guardant Health, Inc. all-time high annual cash & cash equivalents is $1.13B
What is Guardant Health, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, GH annual cash & cash equivalents has changed by -$608.00M (-53.64%)
What is Guardant Health, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of GH is $629.14M
What is the all time high quarterly cash & cash equivalents for Guardant Health, Inc.?
Guardant Health, Inc. all-time high quarterly cash & cash equivalents is $1.94B
What is Guardant Health, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, GH quarterly cash & cash equivalents has changed by -$406.10M (-39.23%)